Clinical Trial Update: Durvalumab + Tremelimumab ± Paclitaxel in Advanced BTC After Platinum Chemotherapy. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating durvalumab with tremelimumab, with or without paclitaxel, for advanced biliary tract cancer after platinum chemotherapy; curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• Durvalumab (durvalumab)
• PACLITAXEL (PACLITAXEL)
• Tremelimumab (tremelimumab)

Snippet

Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group | Conditions: Advanced Biliary Tract Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING